Safety and quality update
14 November 2024
New this month: GLP-1 Agonist guideline December review; ASA clinical guidance about GLP-1 Agonists; Perioperative mortality in New Zealand; webAIRS reaches 12,000 reported incidents.
GLP-1 Agonist guideline December review
ANZCA is grateful for the feedback hitherto received about the GLP-1/GIP receptor agonists - clinical practice guideline. We continue to welcome feedback to ensure the clinical guideline best meet the needs of anaesthetists and patients.
Please send your comments to: [email protected].
American Society of Anaesthesiologists (ASA) clinical practice guidance about GLP-1 Agonists
The ASA recently published new clinical practice guidance about GLP-1 medications.
Perioperative mortality in New Zealand (2023)
The New Zealand Health Quality & Safety Commission recently published a surgery and risk infographic, which summarises 2023 perioperative mortality in New Zealand.
webAIRS reaches 12,000 reported incidents
More than 12,000 incidents have now been reported to webAIRS since its inception in 2009. The milestone reflects the collective efforts of anaesthetists dedicated to improving patient outcomes by contributing de-identified near-miss and adverse event data from Australia and New Zealand.
Anaesthetists registered with ANZCA, ASA or NZSA can easily and anonymously report incidents to webAIRS. The reports provide invaluable data for identifying patterns and developing preventative strategies to improve quality of patient care.
If you're interested in joining the ANZTADC team as an incident analyst, or would like to focus on a particular topic, please reach out to us at [email protected].
To report an incident: webAIRS.
For further information: [email protected].